遠心血液ポンプの世界市場規模は、予測期間中に5.4%のCAGRを記録し、2028年までに1億2,670万USドルに達すると推定されています。遠心血液ポンプは、メンテナンスコストが低い、小型である、設備投資が少ないなどの利点があるため、需要が増加しています。このような遠心血液ポンプの利点が、予測期間中の市場成長を促進すると考えられます。
臨床経験と心臓切開用吸引装置の増加により、機械式遠心血液ポンプの使用が大幅に増加し、短期および長期サポート後の結果が改善されました。循環器領域でのインターベンション手法が発展し、危機的状況にある患者の大半が治療を受けるようになると、この分野では機械式遠心血液ポンプの需要が急激に高まっています。
また、ライフスタイルの変化や生活習慣病の増加も市場の成長に寄与すると考えられます。糖尿病、肥満、心血管疾患などの疾患の増加や、高齢者人口の増加が、心血管治療の需要を高めています。このような疾患の治療には、心臓切開用の吸引装置が使用されますが、このことが予測期間中の市場を牽引すると考えられます。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End Use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
Chapter 3. Centrifugal Blood Pumps Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising incidence of cardiovascular disease
3.4.1.2. Increasing advantages of centrifugal blood pumps
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. High cost of product
3.5. Centrifugal Blood Pumps Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Global Centrifugal Blood Pumps Market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Electronic
4.1.2. Mechanical
4.2. Type Market Share, 2020 & 2028
4.3. Segment Dashboard
4.4. Global Centrifugal Blood Pumps Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Electronic
4.5.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
4.5.2. Mechanical
4.5.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
Chapter 5. Global Centrifugal Blood Pumps Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Ambulatory Surgical Centers
5.1.3. Specialty Clinics
5.1.4. Others
5.2. End Use Market Share, 2020 & 2028
5.3. Segment Dashboard
5.4. Global Centrifugal Blood Pumps Market by End Use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Hospitals
5.5.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
5.5.2. Ambulatory Surgical Centers
5.5.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
5.5.3. Specialty Clinics
5.5.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
5.5.4. Others
5.5.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
Chapter 6. Global Centrifugal Blood Pumps Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2020 & 2028
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2020
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 to 2028:
6.7. North America
6.7.1. U.S.
6.7.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.7.2. Canada
6.7.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8. Europe
6.8.1. U.K.
6.8.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8.2. Germany
6.8.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8.3. France
6.8.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8.4. Italy
6.8.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.8.5. Spain
6.8.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9. Asia Pacific
6.9.1. Japan
6.9.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9.2. China
6.9.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9.3. India
6.9.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9.4. South Korea
6.9.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.9.5. Australia
6.9.5.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.10. Latin America
6.10.1. Brazil
6.10.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.10.2. Mexico
6.10.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.10.3. Argentina
6.10.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.10.4. Colombia
6.10.4.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.11. MEA
6.11.1. South Africa
6.11.1.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.11.2. Saudi Arabia
6.11.2.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
6.11.3. UAE
6.11.3.1. Market estimates and forecast, 2016 - 2028 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competitive Categorization
7.2.1. Innovators
7.2.2. Market leaders
7.2.3. Emerging players
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2020
7.4. Public Companies
7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
7.4.2. Company market share/ranking, by region
7.4.3. Competitive dashboard analysis
7.4.3.1. Market differentiators
7.4.3.2. Synergy analysis: major deals and strategic alliances
7.5. Private Companies
7.5.1. List of key emerging companies/technology disruptors/innovators
7.5.2. Funding outlook
7.5.3. Regional network map
7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
7.5.5. Supplier ranking
7.5.6. Key company profiled
7.5.7. 3M
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Baxter International
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. BraileBiomedica Ltd.
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Getinge AB
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Product benchmarking
7.5.10.4. Strategic Initiative
7.5.11. Kyocera Corporation
7.5.11.1. Company overview
7.5.11.2. Financial performance
7.5.11.3. Product benchmarking
7.5.11.4. Strategic initiatives
7.5.12. LivaNovaPlc
7.5.12.1. Company overview
7.5.12.2. Financial performance
7.5.12.3. Product benchmarking
7.5.12.4. Strategic initiatives
7.5.13. Medtronic
7.5.13.1. Company overview
7.5.13.2. Financial performance
7.5.13.3. Product benchmarking
7.5.13.4. Strategic initiatives
7.5.14. Terumo Corporation
7.5.14.1. Company overview
7.5.14.2. Financial performance
7.5.14.3. Product benchmarking
7.5.14.4. Strategic initiatives
